Using CD40 melanoma positive cells, Amirkhosravi and collaborators demonstrated that activated platelet supernatants containing sCD40L, recombinant soluble CD40L, as well as activated platelets-tumor cells interactions increased procoagulant activity and TF antigen expression in tumor cells and in monocytes [123]. Here, CD40LG is linked to melanoma.